Related Experiment Video
Updated: Jul 14, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
Multi-Component Interventions in Older Adults Having Subjective Cognitive Decline (SCD)-A Review Article
Madhuchhanda Mohanty1,2, Prakash Kumar1
1Department of Occupational Therapy, Amity University, Noida 201301, India.
Geriatrics (Basel, Switzerland)
|January 17, 2023
Summary
Subjective cognitive decline (SCD) in older adults is linked to serious cognitive disorders. Multi-component non-pharmacological interventions show promise for enhancing cognitive performance and managing decline.
Area of Science:
- Gerontology
- Neuroscience
- Cognitive Psychology
Background:
- Subjective cognitive decline (SCD) is a self-reported concern in older adults.
- SCD is significantly associated with neurodegenerative conditions like Alzheimer's disease and mild cognitive impairment.
- Effective management strategies are crucial to enhance cognitive performance and slow cognitive decline.
Purpose of the Study:
- To review multi-component non-pharmacological interventions for managing subjective cognitive decline.
- To explore the effectiveness of these interventions in improving cognitive function in older adults.
Main Methods:
- Literature review of studies on subjective cognitive decline interventions.
- Searches conducted in databases including PubMed, Scopus, and EBSCO.
- Extraction of relevant data on multi-component non-pharmacological interventions for SCD.
Main Results:
- Multi-component non-pharmacological interventions are gaining research attention for SCD management.
- These interventions have demonstrated effectiveness in improving cognitive performance across various domains.
- Evidence suggests these approaches can help suppress the rate of cognitive decline.
Conclusions:
- Multi-component non-pharmacological interventions represent a promising avenue for managing subjective cognitive decline.
- Further research into these interventions can lead to enhanced cognitive health in aging populations.
- These strategies offer a viable alternative or adjunct to pharmacological approaches for cognitive health.
Keywords:
Alzheimer’s diseaseageing disordercognitionmulticomponent nonpharmacological interventionsubjective cognitive declineMore Related Videos
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.4K
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.8K
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...